Breast Engorgement and Galactorrhea during Magnesium Sulfate Treatment of Preterm Labor

Samuel Lurie; Sigi Rotmensch; Noa Feldman; Marek Glezerman

doi:10.1055/s-2002-33086

American Journal of Perinatology, Inhaltsverzeichnis

Am J Perinatol 2002; 19(5): 239-240
DOI: 10.1055/s-2002-33086

Breast Engorgement and Galactorrhea during Magnesium Sulfate Treatment of Preterm Labor

Samuel Lurie, Sigi Rotmensch, Noa Feldman, Marek Glezerman

Department of Obstetrics and Gynecology, Wolfson Medical Center, Holon, Israel

Abstract

ABSTRACT

Breast engorgement and galactorrhea occasionally occur during tocolysis with ritodrine. We are not aware of breast engorgement and galactorrhea associated with other tocolytics. We report the first case of breast engorgement and galactorrhea during tocolysis with intravenous magnesium sulfate in a generally healthy 24-year-old woman admitted for tocolysis at 30 weeks' gestation. Breast engorgement and galactorrhea gradually subsided after magnesium sulfate was discontinued. The rapid disappearance of both the galactorrhea and the breast engorgement after discontinuation of magnesium sulfate treatment suggests a cause-effect relationship, the mechanism of which remains unclear.

KEYWORDS

Galactorrhea - preterm labor - tocolysis

Volltext

Referenzen

REFERENCES

1 Biswas S, Rodeck C H. Plasma prolactin levels during pregnancy. Br J Obstet Gynaecol . 1976; 83 683-687
2 Shalev J, Frankel Y, Eshkol A, Serr D M. Breast engorgement and galactorrhea after preventing premature contractions with ritodrine. Gynecol Obstet Invest . 1984; 17 190-193
3 Wellnitz O, Bruckmaier R M, Albrecht C, Blum J W. Atosiban, an oxytocin receptor blocking agent: pharmacokinetics and inhibition of milk ejection in dairy cows. J Dairy Res . 1999; 66 1-8
4 Reynolds J EF. Martindale: The Extra Pharmacopoeia. 13th ed. London: The Pharmaceutical Press 1993: 138,712-725